Background Accurate and consistent risk assessment is vital for the protection of research participants. Yet, current evaluation of the risks of research interventions often does not take into account the relevant empirical data. This approach raises concern that current practice may not be protecting research participants adequately, or that it may be thwarting acceptable research. Purpose To propose and evaluate the possibility of creating and maintaining a Research Risk Repository which would make empirical data on the risks of research interventions available to institutional review boards, investigators, funders, and others. Methods Analysis of the usefulness of a Research Risk Repository and evaluation of whether currently available empirical data are sufficient to establish such a repository. Results Creation of a Research Risk Repository would provide a vital resource for systematically and accurately evaluating the risks of biomedical research. Realizing this goal requires data that have at least 4 characteristics: (1) trustworthy: to ensure credibility to all stakeholders; (2) robust: to support confident risk determinations; (3) inclusive: to cover all potential harms of the interventions under review; and (4) comprehensive: to determine which factors influence the risks of the interventions under review. Evaluation of existing data reveals that they satisfy these requirements for only a few research interventions and, even in those cases, only to a limited extent. Gaps in the currently available evidence highlight the need for systematic collection and maintenance of data on the risks posed by research interventions. Limitations Creation and maintenance of a Research Risk Repository would be costly and require regular updating as new data are collected, and new practices and interventions emerge.
common research interventions. As a result, institutional review boards (IRBs) and others currently evaluate the risks of biomedical research based largely on intuition alone.
The problems with relying on intuition alone are highlighted by extensive empirical data from psychology, which reveal that intuitive evaluation of risks is strongly influenced by numerous cognitive biases [1] [2] [3] [4] . For example, people tend to judge familiar activities as less risky than unfamiliar ones. This bias increases the chances that those familiar with an intervention will judge it to be low risk, while those not familiar with the intervention will judge it to be higher risk.
This concern is reinforced by empirical studies which find significant variation in the assessment of research risks [5] [6] [7] . In a survey of 188 IRB chairpersons in the U.S., 23% categorized allergy skin testing as minimal risk in healthy 11-year olds, 43% categorized the same procedure, in the same population, as a minor increase over minimal risk, and 27% categorized it as more than a minor increase over minimal risk [5] .
It is unlikely that the actual risks of allergy skin testing in healthy 11-year olds vary to this extent between sites, suggesting that the current evaluation of research risks does not always reflect the risks that research participants face. Some may be underestimating the risks posed by research interventions, and thereby failing to protect participants from excessive risks. Others may be overestimating the risks, and thereby potentially blocking acceptable research. Variation in risk judgments across sites also poses a significant obstacle to important research that must be conducted in multiple sites, such as research with children and research on rare diseases.
The present paper proposes and evaluates the feasibility of establishing a Research Risk Repositorya centralized database that would store and make available to IRBs, investigators, funders, and others, systematic data on the risks of research interventions. Creation of a Research Risk Repository would provide the data necessary for making accurate and consistent risk evaluations, thus helping to better protect research participants from excessive risks, while promoting important research consistent with adequate subject protection.
The need for a Research Risk Repository
To assess the risks of research interventions, such as lumbar puncture and allergy skin testing, IRBs could rely on empirical data obtained at their local institutions. This approach has the virtue of basing risk assessments on data that reflect local circumstances. However, it leaves IRBs without a way to systematically evaluate the risks of interventions performed at their institutions for the first time. Furthermore, while local risk data often are necessary for judging research risks accurately, they typically are not sufficient. Data from one or even several institutions often will not include enough data points to capture low probability events, such as the risk of anaphylactic shock from allergy skin testing. To capture these events, and adequately protect research participants, IRBs need access to large datasets on the risks of research interventions.
One way to address this need would be to establish a Research Risk Repository -a database that maintains the available data on the outcomes of research interventions, and makes these data widely accessible. A Research Risk Repository would help IRBs to assess accurately the risks of research interventions. IRBs also could use the repository to identify ways to reduce risks to participants. For example, if the repository reveals that using a narrower needle significantly reduces the likelihood of postdural headache following lumbar puncture, reviewers could consider requiring investigators to use narrower needles.
Investigators also could rely on the repository when writing consent forms and discussing research risks with prospective participants. Similarly, the dataset would allow quality managers to compare the outcomes for research interventions across institutions, and use this information to improve institutional practices. Finally, investigators, sponsors, and IRBs could use the repository to identify gaps in the available data and consider ways to collect additional data. For example, IRBs could require collection of more data during a study when the existing evidence suggests that the risks of the interventions being used are acceptable, but the available data are incomplete. This approach would allow IRBs to confirm the assumption on which they approve such studiesnamely, that the risks are acceptable. In addition, funders, such as the NIH, could identify gaps in the empirical data and invite investigators to collect the needed data.
Four criteria
To provide the data needed to evaluate the risks of research interventions accurately, a Research Risk Repository would need to satisfy at least four criteria.
Criterion #1: The data in the repository should be trustworthy to the various stakeholders in research
Perhaps the best way to promote trust would be for the repository to be operated by an independent non-profit organization. The work of this organization could be overseen by a committee of experts. A
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A Rid and D Wendler searchable online version of the repository would help to increase accessibility and promote accountability and trustworthiness. To avoid discouraging institutions from contributing to the repository, the online version could anonymize the origins of the data.
Criterion #2: The evidence should be sufficiently robust and up to date to support confident risk determinations
The data in the repository should capture as many observations as possible, made in diverse settings. The available data also should be updated as new data are collected. This is particularly important when techniques change in ways that likely influence the risks of interventions such as the introduction of narrower needles for lumbar puncture or CT scanning techniques using increased levels of radiation. (20-22 G) , or large (16-19 G) . Similarly, where relevant, it will be important to specify the extent to which interventions pose greater or lower risks in specific populations, such as children.
Evaluation of feasibility
Review of existing risk data
The most straightforward way to create a Research Risk Repository would be simply to collect and collate existing empirical data on the risks of research interventions. To maximize its usefulness, the repository should focus, at least initially, on common research interventions that are used in contexts which do not offer participants the potential for clinical benefit, such as biopsies performed for research purposes. Research interventions that pose risks to participants without a compensating potential for clinical benefit raise the greatest ethical concern. Moreover, whether the risks of these 'nonbeneficial' interventions are classified as 'minimal' or greater than minimal has important practical implications. For example, most current guidelines and regulations allow non-beneficial interventions to be performed in healthy children only when they pose minimal risks.
To evaluate whether existing data satisfy the four criteria for a Research Risk Repository, we conducted a preliminary literature search on the risks of common research interventions (Figure 1 ). To be included in the search, the interventions had to meet the following requirements: (1) performed routinely in the research setting; (2) often performed for research purposes only; and (3) sufficient data are likely available on the risks posed by the intervention.
We started by classifying research interventions in 10 categories: (1) asking questions (e.g. survey of health-related behaviors); (2) physical examination (e.g. blood pressure measurement); (3) imaging (e.g. ultrasound, CT scan); (4) measuring electrical activity (e.g. ECG, EEG); (5) sampling fluids or cells (e.g. blood draw, apheresis); (6) removing tissue (e.g. skin or muscle biopsy); (7) instilling substances (e.g. allergy skin testing, trial of an investigational drug); (8) genetic testing (e.g. genetic test on previously obtained sample); (9) hospitalization (e.g. overnight stay in hospital); (10) record keeping (e.g. record confidential medical information). In consultation with 25-30 clinical experts or biomedical researchers, IRB members, and experts in research ethics, we drafted a list of 33 research interventions that met the first two inclusion criteria ( Figure 1 ). We then briefly surveyed the relevant literature to determine whether the existing data were likely to satisfy the third inclusion criterion of including sufficient data points on the risks of the 33 interventions.
This process, together with consultation with our group of experts, led to the exclusion of sixteen interventions for which sufficient data were unlikely to be available. For example, we could not identify pertinent data on repeat blood sampling, defined as a series of 5-10 and 10-20 blood draws of a maximum of 10 cc each. Although some studies record the 
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A Rid and D Wendler volume of diagnostic blood loss in the inpatient setting, they often do not estimate the clinical impact. Analogies to blood donation are weak because the data on the risk of anemia and iron depletion in this setting are scarce and/or outdated [9] . Similarly, the clinical implications of exposure to low dose radiation remain unclear [11] . We thus excluded imaging interventions involving radiation, such as X-rays and CT scans. Table 1 shows the list of interventions included in the review of existing risk data.
To identify the highest quality datasets for the remaining 17 interventions (see online Appendix 1), we retrieved citations from PubMed combining the MeSH term for the given research intervention (e.g. 'skin tests' for allergy skin test) with MeSH terms for risk (e.g. risk OR adverse effects), and included all studies published in English on or before 10 January 2009 (see Table 2 for search strategy). The first author (AR) then contacted an independent clinical expert or researcher with the results. One expert per procedure was contacted. Only two of the consulted experts worked outside of NIH at the time. The experts helped to select the highest quality references and identified important papers or book chapters that were not retrieved by the search, often in consultation with their colleagues.
The first author (AR) and a research assistant catalogued the retrieved risk data for each intervention in a table (see Table 3 for the template table), arranging potential physical harms and associated likelihoods (given per 100,000) according to body systems. Potential psychological and social or economic harms were listed separately, if available. Data that were gathered exclusively in pediatric populations were shaded in grey. Each table also indicates the total number of observations in the cited studies (i.e. the total number of interventions performed or the number of observed cases in the context of case reports), and provides relevant information about the respective study contexts. A 95% confidence interval (95% CI) for proportions was calculated using the Wilson formula (Wilson score interval [11] ). The calculations were performed with open source software of the 'R foundation for statistical computing' (http://www.r-project.org/). The identified clinical experts or researchers provided the first author (AR) with a detailed description of the potential harms resulting from the given research intervention, including the type, duration, and reversibility of each potential harm. The experts also provided likelihood estimates for potential harms not provided in the literature, as well as general comments on the quality of the data obtained and relevant background information on the given intervention (online Appendix 1). Finally, the experts helped to develop 'summary tables' for each intervention (online Appendix 2). With the exception of the table on moderate sedation for children, the summary tables do not reflect data collected in pediatric populations.
Results of the review
The review yielded empirical data on the risks of the 17 included interventions. The searches retrieved from 3 to 35 references per intervention that the clinical experts or researchers judged to be of sufficient quality to support risk determinations. The number of observations in the individual datasets ranged from 50 to several 100,000. For several interventions, including ECG and EEG, the search identified case reports only. The tables listing the data of each intervention, as well as summary tables developed in consultation with experts, are available in the online appendices. 
Research risk repository 709
The reviewed literature used a wide range of approaches to evaluate risks. The two dominant approaches were (1) retrospective analysis of existing data, for example from existing medical or research records, and (2) surveys that ask members of professional societies to report on the incidence of adverse events for a given procedure and time interval. Other methods included prospective studies, case reports, review papers, and published expert opinion. The available data often varied in the types of potential harms that were reported for each intervention, and how these potential harms were defined (if they were defined at all). Some of the reported likelihoods for a given potential harm also varied considerably. In some cases, the reported upper likelihood differed from the reported lower likelihood by a factor of 20-30 (online Appendix 1 and 2). Table 4 offers a sample table of the available data on epicutaneous allergy skin testing.
Do existing data meet the 4 criteria for a Research Risk Repository?
While our search was not relevant to determining whether the obtained data would be regarded as trustworthy by relevant stakeholders (Criterion #1), it does provide evidence on the extent to which the available data meet the other three criteria (see online Appendix 1 for evidence supporting the examples used in this section).
Criterion #2: Are the available data sufficiently robust and up to date?
Based on expert opinion, we included only those research interventions in the search that were expected to yield sufficient risk data. Even so, the quality of the available risk data varied greatly. We found essentially no data on interventions generally perceived to be low risk. For example, our search identified only three studies on the risks of i.v. glucose tolerance testing, and one paper that cites some data as a personal communication. While this finding may reflect the fact that serious harms from glucose tolerance testing are unlikely to occur, the repository needs to clearly distinguish an absence of systematic data on the risks of a given intervention from systematic data pointing to an absence of risks for that intervention. In addition, the data often were based on low numbers of observations, which is reflected in large confidence intervals. This shortcoming likely will be difficult to overcome by summarizing data from existing datasets due to a surprising lack of common definitions for potential harms or adverse events. Some datasets did not provide any definitions of the reported adverse events. In other cases, the different datasets used conflicting definitions. For example, i.v. catheters pose a risk of phlebitis. But, some studies defined phlebitis as the occurrence of any local symptoms, such as redness, swelling, local heat, tenderness, or a palpable venous cord. Other studies defined phlebitis as requiring the presence of two, sometimes three, of these symptoms.
Finally, some of the available risk data reflect outdated practices. For example, the largest available datasets on the risks of percutaneous liver biopsy were collected in the 1970s/1980s when the biopsies were done without ultrasound guidance, typically by general internists without specialist training. Quality of data -Retrospective data analysis [12, 13] , physician surveys [17] [18] [19] , prospective study [13] .
-Data include pediatric patients without specifying risks for children; only one study with specific pediatric data [16] .
-Incidence of adverse events is probably too high: studies do not have placebo control arms, so it is possible that random allergic reaction coincided with allergy skin testing (evidence for this in [12] ). Background information -Each epicutaneous skin test involves on average 15-30 pricks per patient (testing the same number of allergens).
-Pain from superficial skin prick is similar to or less than pain from blood draw.
-Local reaction involves intense pruritus for about 10-15 min.
-Systemic reaction ~85% mild reaction: self-limiting hay fever symptoms involving sneezing, runny nose and itching eyes for~1 h, urticaria with recovery under antihistamine treatment in 1 h. ~15% moderate to severe reaction: asthmatic symptoms, hypotension, requires epinephrine treatment. -Anaphylactic shock: essentially no risk due to monitoring and early intervention.
For comparison: risk of anaphylactic shock in immunotherapy is 1 per 2-2.5 million injections [17] . -~85% of research focuses on inhaled allergens (asthma studies),~15% focus on food allergens.
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A Rid and D Wendler The available data were almost exclusively collected in the clinical context. Because risk data specifically from the research context are largely absent, it is difficult to assess to what extent this finding confounds the available evidence. Recorded risks might be lower in the research setting because research institutions often have more staff, are better equipped, and typically have a higher level of safety monitoring. In addition, the clinical context can introduce confounding factors that might increase risks. For example, the available data on the risks of lymph node biopsy were collected primarily in oncology patients who underwent sentinel lymph node biopsies. These biopsies tend to be deeper than research biopsies and thus pose a higher risk of nerve injury than they would in healthy research participants.
Implications
The need to collect more data
The conclusion that existing risk data are not sufficiently robust, inclusive, and comprehensive raises additional concern that current evaluations of research risks, even when they appeal to the available data, may not accurately reflect the risks faced by research participants. This finding provides compelling support for establishing a Research Risk Repository. Our literature search also offers several lessons pertinent to collecting the data necessary to establish such a repository.
First, significant additional data are needed on a number of common research interventions. To adequately reflect current practice, these data should be collected in multiple institutions and settings. Second, common definitions of adverse events, as well as coding systems to classify different practices and settings, need to be developed for most research interventions. Third, a Research Risk Repository is likely to be limited to interventions for which standard practices are recognized. It is impossible to collate data when there are no standard practices, or when standard practice varies widely, as currently is the case with moderate sedation and several other interventions (online appendices).
Present uses of the available risk data
Creating a Research Risk Repository is likely to take a significant amount of time. Given the pressing need to improve risk judgments, IRBs, investigators, sponsors, and others can cautiously consider the results of our preliminary literature search when they assess the risks of research interventions. When doing so, users need to carefully judge both the quality of the data and their relevance for the study under consideration. Notably, the strength of the data varies for the different interventions from very weak to very strong. For example, the literature on gadolineum-based contrast agents, which are used during imaging interventions, includes datasets with hundreds of thousands of observations. Recognizing that these data are lacking in detail and contextual factors, they are overall robust, and thus merit serious consideration (online appendices). When estimates about the likelihood of particular harms vary, users should carefully consider the confidence interval for the likelihood point estimates, generally erring on the side of caution and giving more weight to higher likelihood estimates. Users also need to judge, based on the limited information available on contextual factors, to
